Swiss National Bank’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$132M Buy
234,380
+15,200
+7% +$9.75M 0.08% 226
2025
Q4
$148M Sell
219,180
-12,720
-5% -$8.66M 0.09% 186
2025
Q3
$148M Sell
231,900
-13,400
-5% -$8.13M 0.09% 200
2025
Q2
$132M Buy
245,300
+14,300
+6% +$6.84M 0.08% 220
2025
Q1
$97M Sell
231,000
-1,600
-0.7% -$695K 0.07% 252
2024
Q4
$96.2M Sell
232,600
-12,500
-5% -$5.48M 0.06% 258
2024
Q3
$124M Sell
245,100
-900
-0.4% -$437K 0.08% 216
2024
Q2
$120M Sell
246,000
-2,700
-1% -$1.36M 0.08% 206
2024
Q1
$134M Sell
248,700
-10,900
-4% -$5.96M 0.09% 195
2023
Q4
$144M Sell
259,600
-7,500
-3% -$3.52M 0.11% 176
2023
Q3
$117M Sell
267,100
-32,600
-11% -$16.3M 0.09% 208
2023
Q2
$151M Sell
299,700
-29,000
-9% -$13.9M 0.1% 179
2023
Q1
$164M Sell
328,700
-9,600
-3% -$4.59M 0.11% 171
2022
Q4
$138M Sell
338,300
-25,736
-7% -$9.99M 0.1% 210
2022
Q3
$119M Sell
364,036
-1,500
-0.4% -$551K 0.08% 236
2022
Q2
$128M Sell
365,536
-1,700
-0.5% -$693K 0.09% 223
2022
Q1
$201M Buy
367,236
+43,800
+14% +$23M 0.11% 164
2021
Q4
$213M Sell
323,436
-13,800
-4% -$8.66M 0.13% 135
2021
Q3
$210M Sell
337,236
-11,100
-3% -$7.46M 0.13% 131
2021
Q2
$220M Buy
348,336
+20,311
+6% +$11.2M 0.14% 135
2021
Q1
$161M Buy
328,025
+6,800
+2% +$3.41M 0.11% 179
2020
Q4
$161M Sell
321,225
-9,400
-3% -$4.21M 0.11% 164
2020
Q3
$130M Sell
330,625
-6,900
-2% -$2.55M 0.1% 187
2020
Q2
$111M Buy
337,525
+4,600
+1% +$1.33M 0.09% 201
2020
Q1
$80.6M Buy
332,925
+61,300
+23% +$16M 0.09% 231
2019
Q4
$70.9M Sell
271,625
-12,300
-4% -$3.24M 0.07% 284
2019
Q3
$77.2M Buy
283,925
+3,425
+1% +$953K 0.08% 255
2019
Q2
$77.2M Sell
280,500
-7,300
-3% -$1.8M 0.08% 257
2019
Q1
$64.4M Buy
287,800
+6,100
+2% +$1.26M 0.07% 290
2018
Q4
$52.4M Buy
281,700
+4,400
+2% +$902K 0.07% 292
2018
Q3
$69.2M Sell
277,300
-11,300
-4% -$2.74M 0.08% 274
2018
Q2
$62.9M Buy
288,600
+8,800
+3% +$1.81M 0.07% 291
2018
Q1
$53.6M Sell
279,800
-42,100
-13% -$7.77M 0.07% 312
2017
Q4
$50.3M Sell
321,900
-2,600
-0.8% -$409K 0.05% 366
2017
Q3
$50.5M Buy
324,500
+3,300
+1% +$522K 0.06% 349
2017
Q2
$51.8M Buy
321,200
+3,500
+1% +$568K 0.06% 334
2017
Q1
$49.1M Buy
317,700
+70,000
+28% +$9.65M 0.06% 339
2016
Q4
$29M Hold
247,700
0.05% 423
2016
Q3
$27.9M Sell
247,700
-3,400
-1% -$358K 0.04% 427
2016
Q2
$23.3M Buy
251,100
+97,900
+64% +$8.41M 0.04% 472
2016
Q1
$11.6M Buy
153,200
+28,700
+23% +$2.07M 0.02% 596
2015
Q4
$9.08M Sell
124,500
-1,500
-1% -$107K 0.02% 594
2015
Q3
$9.36M Buy
126,000
+15,600
+14% +$1.12M 0.02% 573
2015
Q2
$7.08M Buy
110,400
+400
+0.4% +$27.7K 0.02% 651
2015
Q1
$8.5M Sell
110,000
-3,200
-3% -$249K 0.02% 597
2014
Q4
$8.39M Buy
113,200
+600
+0.5% +$42.1K 0.03% 480
2014
Q3
$6.63M Sell
112,600
-2,400
-2% -$152K 0.03% 563
2014
Q2
$7.68M Sell
115,000
-1,200
-1% -$76.3K 0.03% 528
2014
Q1
$7.05M Buy
116,200
+25,000
+27% +$1.49M 0.03% 543
2013
Q4
$4.85M Sell
91,200
-1,800
-2% -$94.7K 0.02% 633
2013
Q3
$4.63M Sell
93,000
-5,200
-5% -$250K 0.02% 628
2013
Q2
$4.41M Buy
+98,200
New +$4.29M 0.02% 625

Other funds holding IDXX

Swiss National Bank's IDXX Position: Q1 2026 in Review

Swiss National Bank increased its Idexx Laboratories (IDXX) stake by 6.9% in Q1 2026, buying an estimated $9.75M and bringing the position to 234,380 shares worth $132M. The position accounts for 0.08% of the portfolio, ranked #226.

Swiss National Bank first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $220M in Q2 2021. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Swiss National Bank held 234,380 shares of Idexx Laboratories worth $132M as of Q1 2026.
  • Swiss National Bank bought 15,200 Idexx Laboratories shares in Q1 2026, an estimated $9.75M.
  • Idexx Laboratories made up 0.08% of Swiss National Bank's portfolio in Q1 2026, its #226 holding.
  • Swiss National Bank first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Swiss National Bank's Idexx Laboratories position peaked at $220M in Q2 2021.
  • 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.